0001031020-16-000003.txt : 20160106 0001031020-16-000003.hdr.sgml : 20160106 20160106172400 ACCESSION NUMBER: 0001031020-16-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160106 DATE AS OF CHANGE: 20160106 EFFECTIVENESS DATE: 20160106 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lattice Biologics Ltd. CENTRAL INDEX KEY: 0001031020 IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-254670 FILM NUMBER: 161327775 BUSINESS ADDRESS: STREET 1: 16701 NORTH 90TH STREET, SUITE 101 CITY: SCOTTSDALE STATE: AZ ZIP: 85260 BUSINESS PHONE: (480) 563-0800 MAIL ADDRESS: STREET 1: 16701 NORTH 90TH STREET, SUITE 101 CITY: SCOTTSDALE STATE: AZ ZIP: 85260 FORMER COMPANY: FORMER CONFORMED NAME: BLACKSTONE RESOURCES INC /FI DATE OF NAME CHANGE: 19970121 D 1 primary_doc.xml X0707 D LIVE 0001031020 Lattice Biologics Ltd. 16701 NORTH 90TH STREET, SUITE 101 SCOTTSDALE AZ ARIZONA 85260 (480) 563-0800 BRITISH COLUMBIA, CANADA Blackstone Ventures Inc. BLACKSTONE RESOURCES INC /FI Pendisle Resources Limited BLACKSTONE RESOURCES INC /FI Corporation true Guy Sumner Cook 16701 North 90th Street, Suite 101 Scottsdale AZ ARIZONA 85260 Executive Officer Director Cheryl Anne Farmer 16701 North 90th Street, Suite 101 Scottsdale AZ ARIZONA 85260 Executive Officer Director Gregory Charles Davis 16701 North 90th Street, Suite 101 Scottsdale AZ ARIZONA 85260 Executive Officer Mario Stifano 16701 North 90th Street, Suite 101 Scottsdale AZ ARIZONA 85260 Director Catherine Ann Thomas 16701 North 90th Street, Suite 101 Scottsdale AZ ARIZONA 85260 Director Donald A. McInnes 16701 North 90th Street, Suite 101 Scottsdale AZ ARIZONA 85260 Director Biotechnology $1,000,001 - $5,000,000 06b false 2015-12-23 true true true true true Equity included 7,529,705 common shares and 31,375,648 non-voting restricted shares that are convertible, under certain circumstances, into common shares true All shares were issued in an acquisition by Blackstone Ventures Inc. ("Blackstone") of Lattice Biologics, Inc. ("Lattice") via Lattice's merger into a newly-formed subsidiary of Blackstone. Blackstone is known post-merger as Lattice Biologics Ltd. 0 8421063 8421063 0 Shares issued in the transaction were valued at Cdn$0.30 per share. The Total Offering Amount was converted into U.S. dollars based on a 0.7215 Bank of Canada noon exchange rate in effect on December 23, 2015. false 15 0 0 0 false Lattice Biologics Ltd. /s/ Guy Cook Guy Cook Chief Executive Officer 2016-01-06